Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIVN
#1437
LivaNova PLC - Ordinary Shares
80.3
2
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.36%
Monthly Change
-0.37%
6 month change
+15.89%
Year Change
+45.51%
Previous Close
80.0
3
Open
80.3
2
Low
80.3
2
High
80.3
2
Volume
102
Markets
US Stock Market
Healthcare
Medical Devices
LIVN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
48.66 M
53.26 M
53.56 M
53.96 M
54.35 M
54.69 M
55.09 M
Valuation ratios
Enterprise value
3.62 B
4.69 B
3.28 B
3.05 B
2.72 B
3.11 B
4.24 B
Price to earnings ratio
-9.33
-32.62
-34.28
157.94
39.92
-13.83
23.89
Price to sales ratio
3.44
4.28
2.89
2.38
2.02
2.42
3.05
Price to cash flow ratio
-40.51
43.17
42.21
36.57
13.81
13.2
17.97
Price to book ratio
2.88
3.42
2.44
2.14
1.91
2.8
0.92
Enterprise value to EBITDA ratio
8.29
116.02
-82.82
31.3
13.9
5.25
16.57
Profitability ratios
Return on assets %
-0.14
-0.06
-0.04
0.01
0.03
-0.09
0.04
Return on equity %
-0.31
-0.1
-0.07
0.01
0.05
-0.2
0.08
Return on invested capital %
-51.81
-0.14
-13.12
3.05
19.14
41.29
56.01
Gross margin %
67.03
68.19
69.21
66.86
69.48
67.71
70.07
Operating margin %
-28.89
-0.08
-7.51
-5.94
10.3
14.36
12.67
EBITDA margin %
46.83
3.9
-3.88
8.44
15.59
42.6
19.34
Net margin %
-36.93
-13.12
-8.44
1.52
5.04
-17.47
27.8
Liquidity ratios
Quick ratio
1.92
0.82
2.54
2.51
2.5
1.16
1.21
Current ratio
2.33
0.97
2.98
2.95
2.87
1.36
1.45
Inventory turnover
2.12
2.83
2.67
2.76
2.59
2.72
0.69
Asset turnover
0.39
0.45
0.45
0.49
0.51
0.53
0.15
Solvency ratios
Debt to assets ratio
0.27
0.11
0.24
0.24
0.25
0.14
0.11
Debt to equity ratio
0.59
0.19
0.45
0.46
0.48
0.31
0.22
Long term debt to total assets ratio
0.27
0.11
0.23
0.24
0.25
0.14
0.11
Long term debt to total equity ratio
0.58
0.18
0.45
0.46
0.47
0.31
0.22
Per share metrics
Operating cash flow per share
-1.63
2.03
1.31
1.38
3.35
4.66
4.51
EBIT per share
6.63
-0.54
-2.03
0.52
2.41
9.57
2.8
EBITDA per share
9
0.8
-0.74
1.8
3.58
10.84
4.61
Total debt per share
13.49
4.73
10.13
10.82
11.5
6.91
5.22
Cash per share
5.2
4.11
4.01
4.92
7.86
11.65
9.18
Net current asset value per share
14.81
13.41
16.57
18.23
20.65
20.2
18.22
Tangible book value per share
1.74
5.59
6.11
7.06
8.4
5.41
5.85
Working capital per share
8.45
-0.35
11.01
12.05
13.47
5.38
5.65
Book value per share
23.02
25.57
22.58
23.57
24.19
22
23.55
News
Artisan International Small-Mid Fund Q2 2026 Portfolio Review
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
LivaNova PLC 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LIVN) 2026-08-05
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say
LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
Can AI Momentum and Embedded Growth Lift BFLY's Q2 Results?
3 Medical Instrument Stocks Betting on GenAI to Ease Industry Hurdles